| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2461 | 2019 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 571 | 2019 |
| Latent autoimmune diabetes in adults (LADA) should be less latent S Fourlanos, F Dotta, CJ Greenbaum, JP Palmer, O Rolandsson, ... Diabetologia 48, 2206-2212, 2005 | 508 | 2005 |
| International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium–glucose cotransporter (SGLT) inhibitors T Danne, S Garg, AL Peters, JB Buse, C Mathieu, JH Pettus, ... Diabetes care 42 (6), 1147-1154, 2019 | 305 | 2019 |
| Insulin resistance is a risk factor for progression to type 1 diabetes S Fourlanos, P Narendran, GB Byrnes, PG Colman, LC Harrison Diabetologia 47, 1661-1667, 2004 | 265 | 2004 |
| The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes S Fourlanos, MD Varney, BD Tait, G Morahan, MC Honeyman, ... Diabetes care 31 (8), 1546-1549, 2008 | 253 | 2008 |
| A clinical screening tool identifies autoimmune diabetes in adults S Fourlanos, C Perry, MS Stein, J Stankovich, LC Harrison, PG Colman Diabetes care 29 (5), 970-975, 2006 | 223 | 2006 |
| New-onset diabetes after kidney transplantation—changes and challenges CJ Yates, S Fourlanos, J Hjelmesaeth, PG Colman, SJ Cohney American Journal of Transplantation 12 (4), 820-828, 2012 | 198 | 2012 |
| Advanced glycation end products are direct modulators of β-cell function MT Coughlan, FYT Yap, DCK Tong, S Andrikopoulos, A Gasser, ... Diabetes 60 (10), 2523-2532, 2011 | 192 | 2011 |
| Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes S Fourlanos, C Perry, SA Gellert, E Martinuzzi, R Mallone, J Butler, ... Diabetes 60 (4), 1237-1245, 2011 | 143 | 2011 |
| SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission PS Hamblin, R Wong, EI Ekinci, S Fourlanos, S Shah, AR Jones, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3077-3087, 2019 | 110 | 2019 |
| The accelerator hypothesis and increasing incidence of type 1 diabetes S Fourlanos, LC Harrison, PG Colman Current Opinion in Endocrinology, Diabetes and Obesity 15 (4), 321-325, 2008 | 101 | 2008 |
| Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes SA Price, A Gorelik, S Fourlanos, PG Colman, JM Wentworth Obesity research & clinical practice 8 (2), e178-e182, 2014 | 91 | 2014 |
| Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin CJ Yates, S Fourlanos, PG Colman, SJ Cohney Transplantation 96 (8), 726-731, 2013 | 87 | 2013 |
| Lipid lowering agents, cognitive decline, and dementia: the three-city study ML Ancelin, I Carrière, P Barberger-Gateau, S Auriacombe, O Rouaud, ... Journal of Alzheimer's Disease 30 (3), 629-637, 2012 | 86 | 2012 |
| Oral vitamin D replacement is effective in chronic liver disease A Rode, S Fourlanos, A Nicoll Gastroentérologie clinique et biologique 34 (11), 618-620, 2010 | 81 | 2010 |
| Type 1 diabetes: lessons for other autoimmune diseases? LC Harrison, MC Honeyman, G Morahan, JM Wentworth, S Elkassaby, ... Journal of Autoimmunity 31 (3), 306-310, 2008 | 70 | 2008 |
| Immunology of type 1 diabetes P Narendran, E Estella, S Fourlanos Qjm 98 (8), 547-556, 2005 | 69 | 2005 |
| Early intervention for diabetes in medical and surgical inpatients decreases hyperglycemia and hospital-acquired infections: a cluster randomized trial M Kyi, PG Colman, PR Wraight, J Reid, A Gorelik, A Galligan, S Kumar, ... Diabetes Care 42 (5), 832-840, 2019 | 63 | 2019 |
| Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial SA McAuley, S Trawley, S Vogrin, GM Ward, S Fourlanos, CA Grills, ... Diabetes Care 45 (2), 381-390, 2022 | 60 | 2022 |
